Celltrion Begins US Phase III Trial For Subcutaneous Infliximab

 
• By Jung Won Shin
  
Celltrion researcher
Celltrion Takes New Drug Approval Pathway For Remsima SC • Source: Celltrion Inc.

More from Biosimilars

More from Products